Vigil Neuroscience's lead clinical candidate, iluzanebart, has failed in a mid-stage study in a rare and fatal neurodegenerative disease. Vigil on Wednesday said it is ending a Phase 2 study of ...

Now, one mom who resides in Southwood is organizing a vigil for Missy Mogle, who died May 19. The event is set for 6:30 p.m. Thursday, May 29 behind the Southwood Community Center and Central ...

RIVERDALE, Utah (KUTV) — Friends and family held a candlelight vigil on Saturday, in honor of Stacey Nicole Scott. Dozens gathered at the Greenhill Apartments, where 33-year-old Scott was found ...

A vigil was held at the London Corbin airport. That’s where survivors, victims’ families, volunteers and more came to pray together, to grieve together, and to remain hopeful together.

The organizers of the vigil are friends of the couple, and they were clear: This was not the time for big speeches — just songs, hugs and prayers. Well over a hundred people gathered just feet ...

BRYA I’LL GIVE YOU THAT IN A FEW MINUTES. ALL RIGHT, BRIAN, THANK YOU. TONIGHT, A VIGIL HONORS THE LIFE OF A FOUR YEAR BOY. RJ O’KEEFE WAS REPORTED MISSING LAST FRIDAY NIGHT. RESCUERS FOUND ...

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its early-stage neurology pipeline. Sanofi announced via a news release dated May ...

SANOFI will acquire Vigil Neuroscience, a clinical-stage biotech company in a $470-million deal, the companies said on Thursday, as the French drugmaker seeks to boost its neurological pipeline ...

Vigil Neuroscience (VIGL) and Sanofi (SNY) announced that it has entered into a definitive merger agreement pursuant to which Sanofi will acquire Vigil for an upfront payment of $8.00 per share of ...

Vigil Neuroscience shares more than tripled Thursday after the company reached a deal to be acquired by Sanofi. French pharmaceutical giant Sanofi agreed to pay $8.00 per share in cash at closing ...

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. With the biotech into the final year of its cash runway, Sanofi has swept in to secure a small molecule ...

Paris, May 22, 2025. Sanofi announced today that it has entered into an agreement to acquire Vigil Neuroscience, Inc. (“Vigil”), a publicly traded clinical-stage biotechnology company focused on ...